JPS562964A - 22*11naphthyl*piperidine derivative* its manufacture and use as antimycotic drug - Google Patents
22*11naphthyl*piperidine derivative* its manufacture and use as antimycotic drugInfo
- Publication number
- JPS562964A JPS562964A JP7708180A JP7708180A JPS562964A JP S562964 A JPS562964 A JP S562964A JP 7708180 A JP7708180 A JP 7708180A JP 7708180 A JP7708180 A JP 7708180A JP S562964 A JPS562964 A JP S562964A
- Authority
- JP
- Japan
- Prior art keywords
- 11naphthyl
- manufacture
- piperidine derivative
- antimycotic drug
- antimycotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 239000003429 antifungal agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH537279 | 1979-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS562964A true JPS562964A (en) | 1981-01-13 |
Family
ID=4292451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7708180A Pending JPS562964A (en) | 1979-06-08 | 1980-06-06 | 22*11naphthyl*piperidine derivative* its manufacture and use as antimycotic drug |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS562964A (en) |
| AU (1) | AU5912180A (en) |
| BE (1) | BE883673A (en) |
| DE (1) | DE3020113A1 (en) |
| DK (1) | DK247180A (en) |
| ES (1) | ES8105287A1 (en) |
| FR (1) | FR2462426A1 (en) |
| GB (1) | GB2051799A (en) |
| IL (1) | IL60248A0 (en) |
| IT (1) | IT8048887A0 (en) |
| NL (1) | NL8003250A (en) |
| PT (1) | PT71362B (en) |
| SE (1) | SE8004234L (en) |
| ZA (1) | ZA803403B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008001381A (en) * | 2006-06-21 | 2008-01-10 | Daizo:Kk | Aerosol products |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2664592B1 (en) * | 1990-07-10 | 1994-09-02 | Adir | NOVEL DERIVATIVES OF PIPERIDINE, TETRAHYDROPYRIDINE AND PYRROLIDINE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| GB9513750D0 (en) * | 1995-07-06 | 1995-09-06 | Sandoz Ltd | Use of allylamines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862103D1 (en) * | 1977-08-19 | 1982-11-18 | Sandoz Ag | Propenyl amines, processes for their production and pharmaceutical compositions containing them |
-
1980
- 1980-05-27 DE DE19803020113 patent/DE3020113A1/en not_active Withdrawn
- 1980-06-04 ES ES492149A patent/ES8105287A1/en not_active Expired
- 1980-06-04 NL NL8003250A patent/NL8003250A/en not_active Application Discontinuation
- 1980-06-04 IT IT8048887A patent/IT8048887A0/en unknown
- 1980-06-04 GB GB8018329A patent/GB2051799A/en not_active Withdrawn
- 1980-06-06 AU AU59121/80A patent/AU5912180A/en not_active Abandoned
- 1980-06-06 DK DK247180A patent/DK247180A/en unknown
- 1980-06-06 JP JP7708180A patent/JPS562964A/en active Pending
- 1980-06-06 SE SE8004234A patent/SE8004234L/en unknown
- 1980-06-06 BE BE1/9840A patent/BE883673A/en unknown
- 1980-06-06 PT PT71362A patent/PT71362B/en unknown
- 1980-06-06 ZA ZA00803403A patent/ZA803403B/en unknown
- 1980-06-06 IL IL60248A patent/IL60248A0/en unknown
- 1980-06-09 FR FR8012749A patent/FR2462426A1/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008001381A (en) * | 2006-06-21 | 2008-01-10 | Daizo:Kk | Aerosol products |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3020113A1 (en) | 1980-12-18 |
| ES492149A0 (en) | 1981-05-16 |
| ES8105287A1 (en) | 1981-05-16 |
| SE8004234L (en) | 1980-12-09 |
| IT8048887A0 (en) | 1980-06-04 |
| GB2051799A (en) | 1981-01-21 |
| PT71362A (en) | 1980-07-01 |
| ZA803403B (en) | 1982-01-27 |
| DK247180A (en) | 1980-12-09 |
| BE883673A (en) | 1980-12-08 |
| NL8003250A (en) | 1980-12-10 |
| IL60248A0 (en) | 1980-09-16 |
| AU5912180A (en) | 1980-12-11 |
| FR2462426A1 (en) | 1981-02-13 |
| PT71362B (en) | 1981-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5764653A (en) | Agmatilene derivative and manufacture | |
| JPS57181043A (en) | Arylcyclobutylamine derivative as medicine and manufacture | |
| NZ193798A (en) | 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions | |
| JPS5636481A (en) | Aminopiperidine* its manufacture* intermediate and medicine | |
| JPS55100313A (en) | Drug composition and its manufacture | |
| JPS55154981A (en) | Novel 33vinyllcephalosporin derivative and its manufacture | |
| JPS55122768A (en) | Hydroxypyrimidine derivative*its manufacture and use | |
| JPS562960A (en) | Pyrrolidinylalkylcarboxylic acid amide derivative* its manufacture and medicinal composition | |
| JPS52133992A (en) | Novel 1*44benzodioxane derivative and its production and pharmaceutical compound | |
| JPS55149272A (en) | Novel 5hhfuranonee2 and 3hhdihydrofuranonee2 derivative* their manufacture and use as medicine | |
| JPS5687569A (en) | Oxybutyllimidazole derivative* its manufacture and its use as bactericide | |
| JPS5661375A (en) | 1*2*44oxadiazolinee55one derivative* its manufacture and drug composition containing same | |
| JPS55108871A (en) | Novel norrtropane derivative*its manufacture and use | |
| PH16220A (en) | Pyrro-lidine derivatives and pharmaceutical compositions thereof | |
| JPS5511592A (en) | Novel phenylpiperidine derivative*its manufacture*pharmaceutic drug containing it and its application | |
| JPS562964A (en) | 22*11naphthyl*piperidine derivative* its manufacture and use as antimycotic drug | |
| JPS55100392A (en) | Novel cephalosporin derivative* its manufacture and use | |
| JPS55115870A (en) | 2*22dimethyll1*22dihydroquinoline derivative and its manufacture and use | |
| JPS5626875A (en) | 44*naphthaleniloxy*piperidine derivatives | |
| JPS55136260A (en) | Phenylethylamine derivative*its manufacture and its medical composition | |
| JPS55162776A (en) | Novel hydantoin derivative* its manufacture and its use | |
| JPS5683479A (en) | Novel oxybenztriazole derivatives* their manufacture and their use | |
| JPS5572172A (en) | Diastereomerr11*44chlorophenoxy**11 *11imidazolyl**3*33dimethyll22butanol*its manufacture and use as drug | |
| PH15436A (en) | 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof | |
| JPS5699472A (en) | 11aminoopropanee22ol derivative* its manufacture and therapeutical composition |